Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.

Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficul...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chikako Nakama, Takahiro Tabuchi
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/0b0b8470e62d4f14818c2e86b8829914
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0b0b8470e62d4f14818c2e86b8829914
record_format	dspace
spelling	oai:doaj.org-article:0b0b8470e62d4f14818c2e86b88299142021-12-02T20:12:47ZUse of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.1932-620310.1371/journal.pone.0260154https://doaj.org/article/0b0b8470e62d4f14818c2e86b88299142021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0260154https://doaj.org/toc/1932-6203Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficulty in quitting smoking, and they may start HTPs use to quit smoking. The purpose of this study is to examine the use of HTPs in people with chronic disease. We used data from an internet study, the Japan Society and New Tobacco Internet Survey (JASTIS). We analyzed 9,008 respondents aged 15-73 years in 2019 using logistic regression. Current use of tobacco products was defined as use within the previous 30 days. Prevalence of current HTP use including dual use and dual use with cigarettes was 9.0% and 6.1% respectively in total. By disease: hypertension 10.2% and 7.4%, diabetes 15.9% and 12.3%, CVD 19.2% and 15.7%, COPD 40.5% and 33.3%, and cancer 17.5% and 11.9%. Diabetes, CVD, COPD, and cancer were positively associated with current use of HTPs (odds ratios (ORs) and 95% confidence intervals (CIs): 1.48 (1.06, 2.07), 2.29 (1.38, 3.80), 3.97(1.73, 9.11), and 3.58(1.99, 6.44), respectively) and dual use of cigarettes and HTPs (ORs and 95% CIs: 2.23 (1.61, 3.09), 3.58 (2.29, 5.60), 7.46 (3.76, 14.80), and 2.57 (1.46, 4.55), respectively) after adjusting for confounders. People with chronic disease were more likely to use HTPs and HTPs together with cigarettes. Further research on the smoking situation of HTPs in patients with chronic diseases is necessary.Chikako NakamaTakahiro TabuchiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0260154 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Chikako Nakama Takahiro Tabuchi Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
description	Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficulty in quitting smoking, and they may start HTPs use to quit smoking. The purpose of this study is to examine the use of HTPs in people with chronic disease. We used data from an internet study, the Japan Society and New Tobacco Internet Survey (JASTIS). We analyzed 9,008 respondents aged 15-73 years in 2019 using logistic regression. Current use of tobacco products was defined as use within the previous 30 days. Prevalence of current HTP use including dual use and dual use with cigarettes was 9.0% and 6.1% respectively in total. By disease: hypertension 10.2% and 7.4%, diabetes 15.9% and 12.3%, CVD 19.2% and 15.7%, COPD 40.5% and 33.3%, and cancer 17.5% and 11.9%. Diabetes, CVD, COPD, and cancer were positively associated with current use of HTPs (odds ratios (ORs) and 95% confidence intervals (CIs): 1.48 (1.06, 2.07), 2.29 (1.38, 3.80), 3.97(1.73, 9.11), and 3.58(1.99, 6.44), respectively) and dual use of cigarettes and HTPs (ORs and 95% CIs: 2.23 (1.61, 3.09), 3.58 (2.29, 5.60), 7.46 (3.76, 14.80), and 2.57 (1.46, 4.55), respectively) after adjusting for confounders. People with chronic disease were more likely to use HTPs and HTPs together with cigarettes. Further research on the smoking situation of HTPs in patients with chronic diseases is necessary.
format	article
author	Chikako Nakama Takahiro Tabuchi
author_facet	Chikako Nakama Takahiro Tabuchi
author_sort	Chikako Nakama
title	Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
title_short	Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
title_full	Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
title_fullStr	Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
title_full_unstemmed	Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
title_sort	use of heated tobacco products by people with chronic diseases: the 2019 jastis study.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/0b0b8470e62d4f14818c2e86b8829914
work_keys_str_mv	AT chikakonakama useofheatedtobaccoproductsbypeoplewithchronicdiseasesthe2019jastisstudy AT takahirotabuchi useofheatedtobaccoproductsbypeoplewithchronicdiseasesthe2019jastisstudy
_version_	1718374805705588736

Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.

Ejemplares similares